|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/437 | |||
| A61P 25/28 |
| (11) | Number of the document | 3532477 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17794524.3 |
| Date of filing the European patent application | 2017-10-20 | |
| (97) | Date of publication of the European application | 2019-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057566 |
| Date | 2017-10-20 |
| (87) | Number | WO 2018/080917 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662412868 P | 2016-10-26 | US |
| (72) |
AMERIKS, Michael K., US
GYURIS, Mįri, HU
LAFORTEZA, Brian Ngo, US
LEBOLD, Terry Patrick, US
MEYER, Stephen Todd, US
RAVULA, Suchitra, US
SAVALL, Brad M., US
SHIREMAN, Brock T., US
WADE, Warren Stanfield, US
GERENCSÉR, Jįnos, HU
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |